TRIM38 and colorectal carcinoma: To elucidate the mechanism underlying TRIM38‐mediated inhibition of CRC progression, we performed immunoprecipitation (IP) using the TRIM38 antibody and conducted mass spectrometry (MS) analysis to identify the proteins interacting with TRIM38 in CRC.